GlassScriptPhysician profile
James Youngchull Kim
NPI 1386684330
$1,973.91
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $551 · 2021: $322 · 2022: $125 · 2024: $30.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $30.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $30.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $322.11 | 2019-2022 | |
| Amgen INC. | $290.52 | 2019-2021 | |
| Glaxosmithkline, LLC. | $243.49 | 2019-2022 | |
| Abbvie INC. | $172.45 | 2019-2022 | |
| Novo Nordisk INC | $161.72 | 2019 | |
| Mannkind Corporation | $101.01 | 2020-2021 | |
| Eisai INC. | $77.04 | 2020-2021 | |
| Astellas Pharma US INC | $66.42 | 2019-2021 | |
| Amarin Pharma, INC. | $58.03 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $54.63 | 2019-2021 | |
| Daiichi Sankyo INC. | $50.42 | 2020-2021 | |
| Ucb, INC. | $45.69 | 2019 | |
| Merck Sharp & Dohme LLC | $39.03 | 2019-2021 | |
| Horizon Therapeutics Plc | $38.50 | 2019-2020 | |
| Janssen Biotech, INC. | $25.45 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $25.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.09 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.82 | 2019 | |
| Lilly USA, LLC | $23.50 | 2019 | |
| Mallinckrodt Enterprises LLC | $17.30 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.77 | 2019 | |
| Irhythm Technologies, INC. | $15.48 | 2024 | Zio Xt Patch, Zio Monitor |
| Teva Pharmaceuticals USA, INC. | $15.05 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.94 | 2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $14.52 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.58 | 2020 | |
| Pfizer INC. | $12.61 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.